Cole Vick is an associate in Axinn’s Antitrust group. Their practice focuses on antitrust litigation and merger review.

Ted Mathias serves as lead counsel in complex patent litigation, often managing cases involving more than 15 patents. He frequently handles matters at the intersection of patent and antitrust law, with a strong focus on advising clients in the pharmaceutical industry.

Craig Minerva, a former lead attorney with the Antitrust Division of the U.S. Department of Justice (DOJ), counsels clients on all aspects of civil antitrust matters with a focus on leading high-stakes, multinational transaction reviews.

Lisl Dunlop brings over 30 years of antitrust experience, helping her clients navigate the complex challenges around mergers, acquisitions, joint ventures, and agency investigations. She focuses on helping clients align their strategic initiatives with antitrust risk, providing practical solutions that move their businesses forward.

Ali Vissichelli is a counsel in Axinn’s Antitrust group. She has experience in civil, multidistrict, and criminal antitrust litigation, as well as complex investigations. She has worked with clients in a range of industries, including financial services and products, technology, healthcare and pharmaceuticals, automobiles, food services, and chemicals. In addition to her litigation and investigation work, Ali has represented clients in merger clearances and compliance with the Hart-Scott-Rodino Act. She has also developed antitrust compliance programs and risk assessments, specifically for clients in the technology and pharmaceutical industries.

Aaron’s practice focuses on patent litigation and counseling, with an emphasis on the life sciences and biotechnology. His experience includes matters before the federal courts and the U.S.  International Trade Commission. Aaron leverages his scientific background to assist clients with biosimilars proceedings, litigation under the Hatch-Waxman Act, and advocacy before the Food and Drug Administration.

Cole Vick is an associate in Axinn’s Antitrust group. Their practice focuses on antitrust litigation and merger review.

Ted Mathias serves as lead counsel in complex patent litigation, often managing cases involving more than 15 patents. He frequently handles matters at the intersection of patent and antitrust law, with a strong focus on advising clients in the pharmaceutical industry.